OrthoPediatrics expands its specialty bracing portfolio with new products for pediatric hip treatment, enhancing care options.
Quiver AI Summary
OrthoPediatrics Corp. has announced the expansion of its OrthoPediatrics Specialty Bracing (OPSB) portfolio with the launch of two new products: the PediHip™ Rigid Brace and PediHip™ Modular Abduction System. These products, designed for children aged three years and younger, are aimed at treating Developmental Dysplasia of the Hip (DDH) and providing post-operative stabilization. This brings the total number of systems within the OPSB division to 31. Joe Hauser, the division president, emphasized the company's commitment to developing innovative solutions in partnership with healthcare providers to improve care for children. With these new additions, along with the recently launched 3P Hip System, OrthoPediatrics aims to offer comprehensive treatment options for pediatric hip care. Founded in 2006, OrthoPediatrics focuses solely on pediatric orthopedics, marketing over 85 products globally to address various orthopedic conditions in children.
Potential Positives
- The launch of two new products, the PediHip™ Rigid Brace and PediHip™ Modular Abduction Systems, enhances OrthoPediatrics' Specialty Bracing portfolio, expanding their offerings to treat Developmental Dysplasia of the Hip (DDH) in pediatric patients.
- Collaboration with globally recognized pediatric hip experts demonstrates OrthoPediatrics' commitment to high-quality, specialized product development in pediatric orthopedics.
- The addition of these new products increases the total number of systems within the OPSB division to 31, indicating growth and innovation in OrthoPediatrics' product lineup.
- OrthoPediatrics' expansion aligns with their focus on organic new product development, reinforcing their position as a leader in pediatric orthopedic solutions.
Potential Negatives
- None
FAQ
What are the new products launched by OrthoPediatrics?
OrthoPediatrics has launched the PediHip™ Rigid Brace and PediHip™ Modular Abduction Systems to treat Developmental Dysplasia of the Hip.
How do the new products benefit pediatric patients?
The new products enhance treatment options for Developmental Dysplasia of the Hip in children aged three and under, benefiting patients and parents.
What is the focus of OrthoPediatrics Corp.?
OrthoPediatrics focuses exclusively on advancing pediatric orthopedics, offering a comprehensive range of products for various orthopedic conditions.
How many systems does OrthoPediatrics have in its OPSB division?
OrthoPediatrics' Specialty Bracing division now includes 31 systems following the launch of the new PediHip™ products.
Where can I find more information about OrthoPediatrics products?
More information about OrthoPediatrics and its products can be found at www.orthopediatrics.com and www.opsb.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$KIDS Insider Trading Activity
$KIDS insiders have traded $KIDS stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $KIDS stock by insiders over the last 6 months:
- FRED HITE (COO and CFO) purchased 5,076 shares for an estimated $98,525
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$KIDS Hedge Fund Activity
We have seen 44 institutional investors add shares of $KIDS stock to their portfolio, and 65 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BROWN CAPITAL MANAGEMENT LLC removed 475,484 shares (-30.5%) from their portfolio in Q3 2025, for an estimated $8,810,718
- WASATCH ADVISORS LP removed 402,223 shares (-56.0%) from their portfolio in Q2 2025, for an estimated $8,639,750
- GRANAHAN INVESTMENT MANAGEMENT, LLC added 299,771 shares (+44.9%) to their portfolio in Q2 2025, for an estimated $6,439,081
- NEW YORK STATE COMMON RETIREMENT FUND removed 254,500 shares (-57.1%) from their portfolio in Q3 2025, for an estimated $4,715,885
- HARBOR CAPITAL ADVISORS, INC. removed 229,270 shares (-68.7%) from their portfolio in Q3 2025, for an estimated $4,248,373
- MORGAN STANLEY added 169,622 shares (+16.1%) to their portfolio in Q2 2025, for an estimated $3,643,480
- GOLDMAN SACHS GROUP INC removed 132,735 shares (-66.2%) from their portfolio in Q2 2025, for an estimated $2,851,147
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$KIDS Analyst Ratings
Wall Street analysts have issued reports on $KIDS in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 10/29/2025
- Needham issued a "Buy" rating on 10/29/2025
- Stifel issued a "Buy" rating on 10/10/2025
- JMP Securities issued a "Market Outperform" rating on 10/10/2025
- Piper Sandler issued a "Overweight" rating on 10/10/2025
- Lake Street issued a "Buy" rating on 10/10/2025
To track analyst ratings and price targets for $KIDS, check out Quiver Quantitative's $KIDS forecast page.
$KIDS Price Targets
Multiple analysts have issued price targets for $KIDS recently. We have seen 6 analysts offer price targets for $KIDS in the last 6 months, with a median target of $24.0.
Here are some recent targets:
- Ryan Zimmerman from BTIG set a target price of $23.0 on 10/29/2025
- Mike Matson from Needham set a target price of $26.0 on 10/29/2025
- Rick Wise from Stifel set a target price of $20.0 on 10/10/2025
- David Turkaly from JMP Securities set a target price of $25.0 on 10/10/2025
- Matt O'Brien from Piper Sandler set a target price of $22.0 on 10/10/2025
- Ben Haynor from Lake Street set a target price of $34.0 on 10/10/2025
Full Release
WARSAW, Ind., Nov. 13, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing (“OPSB”) portfolio with two new products launches, the PediHip™ Rigid Brace and PediHip™ Modular Abduction Systems. The company now has 31 systems within its OPSB division.
Developed in collaboration with globally recognized pediatric hip experts, the PediHip™ Rigid Brace and PediHip™ Modular Abduction System are intended for the treatment of Developmental Dysplasia of the Hip (DDH) and post-operative stabilization in pediatric patients ages three years and younger. These two new products will greatly enhance the current options to treat this condition, ultimately benefiting the patient and parent.
Joe Hauser, OrthoPediatrics Specialty Bracing division President, commented, “We have been focused on organic new product development and are thrilled to announce these two new launches as we continue to strengthen our OPSB portfolio. The PediHip™ portfolio showcases our commitment to partnering with providers to advance care for children. In combination with the Trauma & Deformity portfolio, including the newly launched 3P Hip System, OrthoPediatrics can now provide treatment solutions for the entire pediatric hip care continuum.”
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 85 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com . For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com .
Investor Contact
Philip Trip Taylor
Gilmartin Group
[email protected]
415-937-5406
